A prospective study of patients with diabetic kidney disease showed that the urinary tubular markers, neutrophil gelatinase-associated lipocalin (NGAL), Cystatin C and kidney injury molecule-1 (KIM-1) could independently predict faster eGFR decline and end stage renal disease (ESRD) [8]. This evidence concerns the gene LCN2 and diabetic kidney disease.